News: RAP Resapp Health Says Pfizer Raises Scheme Consideration To A$0.208 Per Share

Aug 5 (Reuters) - Resapp Health Ltd (RAP) :

• PFIZER RAISES SCHEME CONSIDERATION TO A$0.208 PER SHARE
• PFIZER HAS AGREED TO INCREASE SCHEME CONSIDERATION FROM A$0.146 PER SHARE TO A$0.208 PER SHARE IN CASH
• COURT APPROVES DISPATCH OF SUPPLEMENTARY SCHEME BOOKLET
• REVISED SCHEME CONSIDERATION IMPLIES AN EQUITY VALUE ON A 100% FULLY DILUTED BASIS OF APPROXIMATELY A$180 MLN
• REVISED SCHEME CONSIDERATION IS EQUAL TO INDEPENDENT EXPERT'S PREFERRED VALUE OF A RESAPP SHARE
• DIRECTORS OF RESAPP CONTINUE TO UNANIMOUSLY RECOMMEND THAT RESAPP SHAREHOLDERS VOTE IN FAVOUR OF SCHEME